We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Forte Biosciences Inc
8 own
5 watching
Current Price
$1.02
$0.02
(2.27%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
21.42M
52-Week High
1.54
52-Week Low
0.8977
Average Volume
0.03M
Dividend Yield
--
P/E Ratio
--
Market Capitalization21.42M52-Week High1.5452-Week Low0.8977Average Volume0.03MDividend Yield--P/E Ratio--What does the Forte Biosciences Inc do?
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Read More
How much money does Forte Biosciences Inc make?
News & Events about Forte Biosciences Inc.
Ticker Report
5 months ago
Forte Biosciences, Inc. (NASDAQ:FBRX Get Rating) was the recipient of unusually large options trading on Wednesday. Traders purchased 30,205 call options on the company. This represents an increase of 1,663% compared to the typical volume of 1,713 call options. Forte Biosciences Trading Up 2...
Business Wire
11 months ago
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases today announced the issuance of an equity inducement award as required by the Nasdaq Stock Market Rules. In accordance with NASDAQ Listing Rule 5635(c)(4), the Compensation...
Business Wire
11 months ago
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases announces that Dr. Hubert Chen, MD has joined the company as Chief Scientific Officer and President. Dr. Chen is a very accomplished drug development scientist and physician and...
Business Wire
1 year ago
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced first quarter 2022 results and provided a business update. Following a very extensive process by our Board, the management team and external advisors, Forte is...
Ticker Report
1 year ago
Brokerages forecast that Forte Biosciences, Inc. (NASDAQ:FBRX Get Rating) will post earnings of ($0.38) per share for the current fiscal quarter, Zacks reports. Zero analysts have issued estimates for Forte Biosciences earnings. The business is expected to report its next quarterly ...
Frequently Asked Questions
Frequently Asked Questions
What is Forte Biosciences Inc share price today?
Can Indians buy Forte Biosciences Inc shares?
How can I buy Forte Biosciences Inc shares from India?
Can Fractional shares of Forte Biosciences Inc be purchased?
What are the documents required to start investing in Forte Biosciences Inc stocks?
What is today’s traded volume of Forte Biosciences Inc?
What is today’s market capitalisation of Forte Biosciences Inc?
What is the 52-Week High and Low Range of Forte Biosciences Inc?
What percentage is Forte Biosciences Inc down from its 52-Week High?
What percentage is Forte Biosciences Inc up from its 52-Week Low?
Current Price
$1.02
$0.02
(2.27%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.